{"id":30401,"date":"2025-03-19T11:47:44","date_gmt":"2025-03-19T10:47:44","guid":{"rendered":"https:\/\/mabdesign.fr\/?p=30401"},"modified":"2025-03-19T11:47:45","modified_gmt":"2025-03-19T10:47:45","slug":"les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/","title":{"rendered":"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament"},"content":{"rendered":"\n<p><em><strong>Castres (France), Cambridge (Massachusetts) et B\u00e2le (Suisse), 12 mars 2025<\/strong><\/em>\u00a0\u2013 Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&amp;D, ainsi qu&#8217;un contrat de licence en vue d&#8217;identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d&#8217;anticorps biparatopiques (ABP) contre plusieurs cibles. Conform\u00e9ment \u00e0 la strat\u00e9gie d&#8217;innovation des Laboratoires Pierre Fabre, ce partenariat portera sur l&#8217;oncologie de pr\u00e9cision, mais aussi sur la dermatologie et les maladies rares.\u00a0<a href=\"https:\/\/www.pierre-fabre.com\/fr\/article\/partenariat-redridge-bio-developpement-medicaments\">En savoir plus<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&#038;D, ainsi qu&#8217;un contrat de licence en vue d&#8217;identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d&#8217;anticorps biparatopiques (ABP) contre plusieurs cibles. <\/p>\n","protected":false},"author":3,"featured_media":414,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,13],"tags":[],"class_list":["post-30401","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-nos-adherents"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament - MabDesign<\/title>\n<meta name=\"description\" content=\"Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&amp;D, ainsi qu&#039;un contrat de licence en vue d&#039;identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d&#039;anticorps biparatopiques (ABP) contre plusieurs cibles. Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&amp;D, ainsi qu&#039;un contrat de licence en vue d&#039;identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d&#039;anticorps biparatopiques (ABP) contre plusieurs cibles.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&amp;D, ainsi qu&#039;un contrat de licence en vue d&#039;identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d&#039;anticorps biparatopiques (ABP) contre plusieurs cibles. Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&amp;D, ainsi qu&#039;un contrat de licence en vue d&#039;identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d&#039;anticorps biparatopiques (ABP) contre plusieurs cibles.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-19T10:47:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-19T10:47:45+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png\" \/>\n\t<meta property=\"og:image:width\" content=\"425\" \/>\n\t<meta property=\"og:image:height\" content=\"296\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Laure Delhon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laure Delhon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/\"},\"author\":{\"name\":\"Laure Delhon\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\"},\"headline\":\"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament\",\"datePublished\":\"2025-03-19T10:47:44+00:00\",\"dateModified\":\"2025-03-19T10:47:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/\"},\"wordCount\":106,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png\",\"articleSection\":[\"Actualit\u00e9s\",\"Nos adh\u00e9rents\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/\",\"name\":\"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png\",\"datePublished\":\"2025-03-19T10:47:44+00:00\",\"dateModified\":\"2025-03-19T10:47:45+00:00\",\"description\":\"Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles. Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png\",\"width\":425,\"height\":296,\"caption\":\"Pierre Fabre Institut de Recherche\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39\",\"name\":\"Laure Delhon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g\",\"caption\":\"Laure Delhon\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament - MabDesign","description":"Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles. Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/","og_locale":"en_US","og_type":"article","og_title":"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament - MabDesign","og_description":"Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles. Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles.","og_url":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/","og_site_name":"MabDesign","article_published_time":"2025-03-19T10:47:44+00:00","article_modified_time":"2025-03-19T10:47:45+00:00","og_image":[{"width":425,"height":296,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png","type":"image\/png"}],"author":"Laure Delhon","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Laure Delhon","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/"},"author":{"name":"Laure Delhon","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39"},"headline":"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament","datePublished":"2025-03-19T10:47:44+00:00","dateModified":"2025-03-19T10:47:45+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/"},"wordCount":106,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png","articleSection":["Actualit\u00e9s","Nos adh\u00e9rents"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/","url":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/","name":"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png","datePublished":"2025-03-19T10:47:44+00:00","dateModified":"2025-03-19T10:47:45+00:00","description":"Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles. Les Laboratoires Pierre Fabre et RedRidge Bio (\u00ab RedRidge \u00bb) annoncent aujourd\u2019hui une collaboration exclusive en R&D, ainsi qu'un contrat de licence en vue d'identifier et de d\u00e9velopper des candidats-m\u00e9dicaments \u00e0 base d'anticorps biparatopiques (ABP) contre plusieurs cibles.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/12\/pierre-fabre.png","width":425,"height":296,"caption":"Pierre Fabre Institut de Recherche"},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/les-laboratoires-pierre-fabre-et-redridge-bio-annoncent-un-partenariat-concernant-la-decouverte-et-le-co-developpement-de-candidats-medicament\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Les Laboratoires Pierre\u202fFabre et RedRidge\u202fBio annoncent un partenariat concernant la d\u00e9couverte et le co-d\u00e9veloppement de candidats m\u00e9dicament"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/e7f929f9c28647aff12061d31ac44f39","name":"Laure Delhon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/066cd19881c24784247d7cba92fef00a9cef88209b15a463ee495ac0fc2ba664?s=96&d=mm&r=g","caption":"Laure Delhon"},"url":"https:\/\/mabdesign.fr\/en\/author\/laure-delhonmabdesign-fr\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/30401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=30401"}],"version-history":[{"count":1,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/30401\/revisions"}],"predecessor-version":[{"id":30404,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/30401\/revisions\/30404"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/414"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=30401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=30401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=30401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}